Displaying drugs 6276 - 6300 of 6851 in total
UK-396,082
UK-396,082 has been used in trials studying the basic science of Safety, Phase 1, Toleration, Multiple Dose, and Pharmacokinetic.
Investigational
Pactimibe
Pactimibe has been used in trials studying the treatment of Atherosclerosis and Coronary Heart Disease.
Investigational
Buflomedil
Experimental
Oxiracetam
Experimental
(6S)-5,6,7,8-tetrahydrofolic acid
Experimental
RU90395
Experimental
6-hydroxy-FAD
Experimental
GDP-alpha-D-mannuronic acid
Experimental
Cpad
Experimental
Histidyl-Adenosine Monophosphate
Experimental
Adenylosuccinic acid
Experimental
Vapreotide
Vapreotide is a synthetic octapeptide somatostatin analog. It was being studied for the treatment of cancer.
Experimental
Investigational
Matched Iupac: … (2R)-2-amino-N-[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-{[(1S)-1-carbamoyl-2-(1H-indol-3-yl)ethyl …
Temafloxacin
Temafloxacin is an antibiotic agent belonging to the fluoroquinolone drug class. It was first approved for use in the U.S. market in 1992, but was withdrawn shortly due to the reports of serious adverse reactions, such as allergic reactions and hemolyric anemia, resulting in three deaths.
Withdrawn
Alrestatin
Experimental
2-Chlorodideoxyadenosine
Experimental
Genz-10850
Experimental
Gavestinel
Highly potent and selective non-competitive antagonist acting at the strychnine-insensitive glycine binding site of the NMDA receptor-channel complex (Kd = 0.8 nM). Gavestinel displays > 1000-fold selectivity over NMDA, AMPA and kainate binding sites and is orally bioavailable and active in vivo.
Investigational
Displaying drugs 6276 - 6300 of 6851 in total